Gregory Gubitz

Gregory Gubitz is a co-founder and the Chief Executive Officer of HLS Therapeutics Inc, a Canadian-based, North American-focused speciality pharmaceutical company.

Mr Gubitz was Senior Vice President, Corporate Development and General Counsel of Biovail Corporation, formerly Canada’s largest publicly traded pharmaceutical company. In that capacity, he was responsible for mergers & acquisitions and product acquisitions, culminating with the $7 billion merger of Biovail and Valeant Pharmaceutical International Inc.  

Before joining Biovail, for 10 years, he was a senior executive with MDS Capital, a leading North American venture capital company, focused on healthcare. As Chief Operating Officer of MDS Capital, Mr Gubitz was responsible for all operational aspects of the company with a total of $1 billion under management. 

Before joining MDS Capital, Mr Gubitz was a partner at one of Canada’s leading international law firms, where he represented numerous public and private companies in a wide range of financings, mergers & acquisitions, joint ventures, and business transactions.

Mr Gubitz attended McGill University, where he received a Bachelor of Arts Degree in 1979 and a Bachelor of Laws Degree in 1982.  He was called to the Bar in the Province of Ontario in 1984.